Dickinson CJ, SawadaM, Guo YJ, et al. Specificity of pro -hormone convertase endoproteolysis of progastrin in AtT-20 cells[J]. Clin Invest Med, 1995, 96(1): 1 425 -1 431.
[2]
Waldum HL. The cellular localization of the cholecystokinin( gastrin receptor) in the stomach[J]. Acta Pharmacol Toxicol, 2002, 91: 359-362.
[3]
Berna MJ, Tapia JA, Sancho V, et al. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential[J]. Curr Opin Pharmacol, 2007, 7(6): 583-592.
[4]
Philippe Biagini, Genevieve Monges, Vincent Vua-roqueaux, et al. The human gastrin/cholecystokinin receptors: type band type c expression in colonic tumors and cell lines[J]. Life ciences, 1997, 61(10): 1 009-1 018.
[5]
Bettegowda C, Foss CA, Cheong I, et al. Imaging bacterial infections with radiolabeled 1-(2’-deoxy-2’-fluoro-beta-D-arabinofuranosyl)-5-iodouracil[J]. PANS, 2005, 102: 1 145-1 150.
[6]
Lindstrom E, Chen D, Norlen P, et al. Control of gastric acid secretion: targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals[J]. Anticancer Agents Med Chem, 2008, 8(2): 186-199.
[7]
Buursma AR, de Vries EF, Garssen J, et al. [18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis[J]. J Virol, 2005, 79: 7 721-7 727.
[8]
Diaz LA Jr, Foss CA, Thornton K, et al. Imaging of musculoskeletal bacterial infections by [124I]FIAUPET/CT[J]. PLos One, 2007, 10: 2 e1007.
